NEWSROOM
News & Stories
Newsroom
Press Releases
Agendia Co-Founder Laura van โt Veer Wins European Cancer Organization Clinical Research Award
Significant clinical benefit of Agendiaโs MammaPrintยฎ test and other advances in the improved treatment of breast cancer recognized at ceremony during ECCO2017 IRVINE, CA and AMSTERDAM โ 30 January 2017 โ Agendia, Inc., a world Read More
New Data Shows that MammaPrint Substantially Impacts how Breast Cancer Patients in Germany are Treated
PRIMe trial included 452 women at 27 centers in Germany, Austria, and Switzerland Based on the outcome of the MammaPrint test, 28.4% of patientsโ treatment plans were changed, compared to conventional clinico-pathological tests; preventing under Read More
Three New Studies Presented at San Antonio Breast Cancer Symposium Further Demonstrate Value of MammaPrint and BluePrint in Individualizing Treatment for Breast Cancer Patients
Long-term follow-up of early-stage breast cancer patients shows significant difference in how gene expression-based tests classify patients for adjuvant chemotherapy treatment, finds MammaPrintยฎ the best predictor of distant cancer recurrence MINT trial confirms stratification of Read More